疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2014年
7期
728-731
,共4页
马翊竑%张海东%齐军%李峰
馬翊竑%張海東%齊軍%李峰
마익횡%장해동%제군%리봉
芍药苷%血管性痴呆%乙酰胆碱%超氧化物歧化酶%大鼠
芍藥苷%血管性癡呆%乙酰膽堿%超氧化物歧化酶%大鼠
작약감%혈관성치태%을선담감%초양화물기화매%대서
Paeoniflorin%Vascular dementia%Acetylcholine esterase%Superoxide dismutase%Rats
目的:观察芍药苷(PF)对血管性痴呆大鼠学习记忆能力及乙酰胆碱酯酶(AchE)、超氧化物歧化酶(SOD)水平的影响。方法50只Wistar大鼠随机分为假手术组、模型组、给药组(芍药苷低剂量组12.5 mg/kg、中剂量组25 mg/kg、高剂量组50 mg/kg),每组10只。模型组与给药组采用反复夹闭双侧颈总动脉(CCA)结合腹腔注射硝普钠法造模,假手术组不阻断CCA及注射硝普钠。造模后第2天给药组予灌胃给药,模型组与假手术组给予生理盐水灌胃,每天1次,连续30 d。应用Morris水迷宫实验、跳台实验测定大鼠学习记忆能力,并比较各组AchE、SOD活性。结果(1)Morris水迷宫实验:模型组和假手术组定位航行实验中逃避潜伏期均逐渐缩短,第5天明显比第1天短( P <0.05);与假手术组比较,模型组潜伏期在各个时间点均延长,而穿过平台的次数明显减少( P <0.01);与模型组比较,给药组潜伏期呈缩短趋势,第5天比第1天短( P <0.05);穿过平台的次数明显增加( P <0.05或P <0.01)。(2)跳台实验:与假手术组比较,模型组错误次数明显增加,而潜伏期明显缩短( P <0.01);与模型组比较,3个给药组的错误次数均明显降低,潜伏期均高于模型组( P <0.05或P <0.01)。与低、中剂量组比较,高剂量组潜伏期延长更显著( P <0.01)。(3)脑组织匀浆中AchE、SOD活性:与假手术组比较,模型组AchE活性增高、SOD活性降低( P均<0.01);与模型组比较,低、中、高剂量组AchE活性明显降低、SOD活性均升高( P <0.05或P <0.01);与低剂量组相比,高剂量组AchE活性降低( P <0.05),SOD活性明显升高( P <0.01);与中剂量组相比,高剂量组SOD活性升高( P <0.05)。结论芍药苷对血管性痴呆大鼠学习记忆能力障碍有改善作用,其机制之一可能是基于抑制AchE活性,增加SOD的活性。
目的:觀察芍藥苷(PF)對血管性癡呆大鼠學習記憶能力及乙酰膽堿酯酶(AchE)、超氧化物歧化酶(SOD)水平的影響。方法50隻Wistar大鼠隨機分為假手術組、模型組、給藥組(芍藥苷低劑量組12.5 mg/kg、中劑量組25 mg/kg、高劑量組50 mg/kg),每組10隻。模型組與給藥組採用反複夾閉雙側頸總動脈(CCA)結閤腹腔註射硝普鈉法造模,假手術組不阻斷CCA及註射硝普鈉。造模後第2天給藥組予灌胃給藥,模型組與假手術組給予生理鹽水灌胃,每天1次,連續30 d。應用Morris水迷宮實驗、跳檯實驗測定大鼠學習記憶能力,併比較各組AchE、SOD活性。結果(1)Morris水迷宮實驗:模型組和假手術組定位航行實驗中逃避潛伏期均逐漸縮短,第5天明顯比第1天短( P <0.05);與假手術組比較,模型組潛伏期在各箇時間點均延長,而穿過平檯的次數明顯減少( P <0.01);與模型組比較,給藥組潛伏期呈縮短趨勢,第5天比第1天短( P <0.05);穿過平檯的次數明顯增加( P <0.05或P <0.01)。(2)跳檯實驗:與假手術組比較,模型組錯誤次數明顯增加,而潛伏期明顯縮短( P <0.01);與模型組比較,3箇給藥組的錯誤次數均明顯降低,潛伏期均高于模型組( P <0.05或P <0.01)。與低、中劑量組比較,高劑量組潛伏期延長更顯著( P <0.01)。(3)腦組織勻漿中AchE、SOD活性:與假手術組比較,模型組AchE活性增高、SOD活性降低( P均<0.01);與模型組比較,低、中、高劑量組AchE活性明顯降低、SOD活性均升高( P <0.05或P <0.01);與低劑量組相比,高劑量組AchE活性降低( P <0.05),SOD活性明顯升高( P <0.01);與中劑量組相比,高劑量組SOD活性升高( P <0.05)。結論芍藥苷對血管性癡呆大鼠學習記憶能力障礙有改善作用,其機製之一可能是基于抑製AchE活性,增加SOD的活性。
목적:관찰작약감(PF)대혈관성치태대서학습기억능력급을선담감지매(AchE)、초양화물기화매(SOD)수평적영향。방법50지Wistar대서수궤분위가수술조、모형조、급약조(작약감저제량조12.5 mg/kg、중제량조25 mg/kg、고제량조50 mg/kg),매조10지。모형조여급약조채용반복협폐쌍측경총동맥(CCA)결합복강주사초보납법조모,가수술조불조단CCA급주사초보납。조모후제2천급약조여관위급약,모형조여가수술조급여생리염수관위,매천1차,련속30 d。응용Morris수미궁실험、도태실험측정대서학습기억능력,병비교각조AchE、SOD활성。결과(1)Morris수미궁실험:모형조화가수술조정위항행실험중도피잠복기균축점축단,제5천명현비제1천단( P <0.05);여가수술조비교,모형조잠복기재각개시간점균연장,이천과평태적차수명현감소( P <0.01);여모형조비교,급약조잠복기정축단추세,제5천비제1천단( P <0.05);천과평태적차수명현증가( P <0.05혹P <0.01)。(2)도태실험:여가수술조비교,모형조착오차수명현증가,이잠복기명현축단( P <0.01);여모형조비교,3개급약조적착오차수균명현강저,잠복기균고우모형조( P <0.05혹P <0.01)。여저、중제량조비교,고제량조잠복기연장경현저( P <0.01)。(3)뇌조직균장중AchE、SOD활성:여가수술조비교,모형조AchE활성증고、SOD활성강저( P균<0.01);여모형조비교,저、중、고제량조AchE활성명현강저、SOD활성균승고( P <0.05혹P <0.01);여저제량조상비,고제량조AchE활성강저( P <0.05),SOD활성명현승고( P <0.01);여중제량조상비,고제량조SOD활성승고( P <0.05)。결론작약감대혈관성치태대서학습기억능력장애유개선작용,기궤제지일가능시기우억제AchE활성,증가SOD적활성。
Objective To observe the effect of paeoniflorin ( PF) on the vascular dementia rats learning and memory ability, and acetylcholinesterase (AchE), superoxide dismutase (SOD) level.Methods Fifty Wistar rats were randomly di-vided into sham operation group, model group, drug group (paeoniflorin low dose group with 12.5 mg/kg, middle dose group with 25 mg/kg, high dose group with 50 mg/kg), with 10 rats in each group.The model group and the treatment group by re-peated clamping of bilateral common carotid artery ( CCA) model combined with intraperitoneal injection of sodium nitroprus-side, sham operation group did not block the CCA and injection of sodium nitroprusside .After second day of establish the mode , treatment group was given intragastric administration , the model group and the sham operation group were given normal saline, 1 times a day, continuous 30 d.Application of Morris water maze test , step-down test the learning and memory ability of rats, and comparison of AchE, SOD activity.Results (1) Morris water maze experiment:model group and sham operation group positioning navigation test in escape latency gradually shortened , fifth days shorter than first days ( P <0.05); com-pared with the sham operation group , model group were prolonged incubation at each time point , and through the platform was significantly reduced ( P <0.01); compared with the model group , drug group latency showed a trend of shortening , fifth days more shorter than first days ( P <0.05); times across the platform significantly increased ( P <0.05 or P <0.01). (2) In step-down test:compared with the sham operation group , model group, the number of errors increased significantly , and was significantly shortened ( P <0.01);compared with the model group , the 3 groups were significantly decreased the number of errors, the latency was higher than that in the model group ( P <0.05 or P <0.01).Compared with the low,mid-dle dose group, high dose group had significantly more prolonged latency ( P <0.01).(3) AchE, SOD activity of brain ho-mogenates:compared with the sham operation group , model group, AchE decreased, SOD activity increased ( P <0.01);compared with the model group , low, middle and high dose group's AchE activity decreased , SOD activity increased ( P <0.05 or P <0.01);compared with the low dose group , high dose group AchE activity decreased ( P <0.05), the activity of SOD increased significantly ( P <0.01); compared with middle dose group, high dose group's activity of SOD increased (P <0.05).Conclusion Paeoniflorin improved vascular dementia rats learning and memory ability , one of the possible mechanisms is on the basis of inhibition of AchE activity to increase the activity of SOD .